NCT06402500

Brief Summary

The non cavitated white-spot lesion (WSL) occurs after sometime during fixed orthodontic treatments, and their treatment is mandatory before going into frank cavitation. The resin infiltration material (ICON, DMG, America) is considered to be the gold standard resin infiltrationmaterial used for WSL treatment. It is an efficient material in arresting WSLs and has high favorable esthetic recovery. Furthermore, biomaterials like bioactive glass adhesives HI-bond universal adhesive have always been used for replacement, repair and generation of dental hard tissues. The hypotheses of this study are:

  1. 1.There will be no differences in color masking effect on WSLs managed by bioactive glass adhesive or ICON resin infiltration.
  2. 2.There will be no significant addition of mineral content into WSLs after treating it with bioactive glass adhesive HI-Bond universal or with ICON.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 15, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 7, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 7, 2024

Status Verified

May 1, 2024

Enrollment Period

10 months

First QC Date

April 15, 2024

Last Update Submit

May 3, 2024

Conditions

Keywords

Resin infiltrationIncipient lesionbioactive materialICON infiltration resin

Outcome Measures

Primary Outcomes (2)

  • Color masking potential of ICON material in white spot lesions in permanent teeth.

    Photographs will be taken before, immediately after treatment, and 1-month after treatment. These photographs will be used for evaluating of the esthetic outcome by two groups of subjects. The first group comprises the patients themselves. The second group includes dentists. Participants in the evaluation process will will be based on a 100-mm visual analogue scale (VAS). Participants will draw a line on the scale indicating their satisfaction. A line drawn between 0 - 5 cm will mean unsatisfactory outcome while that drawn between 5 - 10 cm will indicate satisfactory outcome.

    6 months

  • Color masking potential of HI-Bond universal material in white spot lesions in permanent teeth.

    Photographs will be taken before, immediately after treatment, and 1-month after treatment. These photographs will be used for evaluating of the esthetic outcome by two groups of subjects. The first group comprises the patients themselves. The second group includes dentists. Participants in the evaluation process will will be based on a 10-cm visual analogue scale (VAS). Participants will draw a line on the scale indicating their satisfaction. A line drawn between 0 - 5 cm will mean unsatisfactory outcome while that drawn between 5 - 10 cm will indicate satisfactory outcome.

    6 months

Secondary Outcomes (3)

  • The remineralisation potential of HI-Bond universal material of white spot lesion (WSL) in permanent teeth.

    3 months

  • The remineralisation potential of HI-Bond universal material in the deepest point of the white spot lesion (WSL) in permanent teeth.

    3 months

  • The remineralisation potential of HI-Bond universal material on lesion area (pixels) of white spot (WSL) in permanent teeth.

    3 months

Study Arms (2)

ICON resin group

EXPERIMENTAL

Clean the white spot with prophylactic paste and then infiltrate the lesion with ICON resin.

Drug: Icon Infiltrant

Bioactive resin group

EXPERIMENTAL

Clean the white spot with prophylactic paste and then infiltrate the lesion with bioactive resin.

Drug: Bioactive infiltrant

Interventions

White spot lesions are treated with the resin ICON (DMG, NJ, US) for masking their color. The mineral content will be measured in the lesion at baseline and after one month Quantitative light-induced fluorescence QLF.

Also known as: ICON (DMG, NJ, US)
ICON resin group

White spot lesions are treated with HI-Bond universal bioactive resin (MEDICLUS, south Korea) for masking their color. Mineral content will be measured in the lesion at baseline and after one month Quantitative light-induced fluorescence QLF.

Also known as: MEDICLUS, Cheongju-si, south Korea
Bioactive resin group

Eligibility Criteria

Age12 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Anterior and premolar maxillary and mandibular teeth.
  • Teeth with no previous restorations.
  • post-orthodontic white spot lesions WSL with no adjacent restorations in the same tooth.
  • WSL on Labial surfaces of maxillary or mandibular anterior and premolars teeth.

You may not qualify if:

  • Cavitated enamel surface that requires direct composite restorations.
  • Presence of developmental enamel defects on the proposed teeth.
  • Diabetic patients and patients with metabolic syndrome.
  • Pregnant ladies.
  • Smoker patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jordan University of Science and Technology

Irbid, 21110, Jordan

RECRUITING

MeSH Terms

Interventions

icon infiltrant

Study Officials

  • Zakereyya SM Albashaireh, PhD

    Jordan University of Science and Technology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zakereyya SM Albashaireh, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The patients who participated in the study and the assessor of the treatment outcome did not know the type of treatment procedure received.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Split mouth study design, patients will be assigned to two different treatment protocols.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2024

First Posted

May 7, 2024

Study Start

December 1, 2023

Primary Completion

September 30, 2024

Study Completion

December 31, 2024

Last Updated

May 7, 2024

Record last verified: 2024-05

Locations